{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:46:40Z","timestamp":1791586000520,"version":"4.3.4"},"reference-count":27,"publisher":"Siapec Servizi Srl","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-1385","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:15:39Z","timestamp":1779264939000},"page":"72-84","source":"Crossref","is-referenced-by-count":2,"title":["Detection of NTRK gene fusions in sarcomas: a comparative study of Pan-TRK immunohistochemistry, FISH, and RNA-Based NGS"],"prefix":"10.32074","volume":"118","author":[{"given":"Stefania","family":"Cocchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gambarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Gamberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Magagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Maioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Sciulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Righi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Benini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21774","published-online":{"date-parts":[[2026,5]]},"reference":[{"key":"10.32074\/1591-951X-1385_ref1","doi-asserted-by":"crossref","unstructured":"Gatalica Z, Xiu J, Swensen J, et al. Molecular characterization of cancers with NTRK gene fusions. Mod Pathol 2019;32:147-153. https:\/\/doi.org\/10.1038\/s41379-018-0118-3","DOI":"10.1038\/s41379-018-0118-3"},{"key":"10.32074\/1591-951X-1385_ref2","doi-asserted-by":"crossref","unstructured":"Amatu A, Sartore-Bianchi A, Bencardino K, et al. Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer. Ann Oncol 201;30:viii5-viii15. https:\/\/doi.org\/10.1093\/annonc\/mdz383","DOI":"10.1093\/annonc\/mdz383"},{"key":"10.32074\/1591-951X-1385_ref3","doi-asserted-by":"crossref","unstructured":"Khotskaya YB, Holla VR, Farago AF, et al. Targeting TRK family proteins in cancer. Pharmacol Ther.2017;173:58-66. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.02.006","DOI":"10.1016\/j.pharmthera.2017.02.006"},{"key":"10.32074\/1591-951X-1385_ref4","doi-asserted-by":"crossref","unstructured":"Agaram NP, Zhang L, Sung YS, et al. Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors. Am J Surg Pathol 2016;40:1407-1416. https:\/\/doi.org\/10.1097\/PAS.0000000000000675","DOI":"10.1097\/PAS.0000000000000675"},{"key":"10.32074\/1591-951X-1385_ref5","doi-asserted-by":"crossref","unstructured":"Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO Classification of Soft Tissue: news and perspectives. Pathologica 202;11370-84. https:\/\/doi.org\/10.32074\/1591-951X-213","DOI":"10.32074\/1591-951X-213"},{"key":"10.32074\/1591-951X-1385_ref6","doi-asserted-by":"crossref","unstructured":"Kallen ME, Hornick JL. The 2020 WHO Classification: What\u2019s New in Soft Tissue Tumor Pathology? Am J Surg Pathol 2021;45:e1-e23. https:\/\/doi.org\/10.1097\/PAS.0000000000001552","DOI":"10.1097\/PAS.0000000000001552"},{"key":"10.32074\/1591-951X-1385_ref7","doi-asserted-by":"crossref","unstructured":"Davis JL, Al-Ibraheemi A, Rudzinski ER, et al. Mesenchymal neoplasms with NTRK and other kinase gene alterations. Histopatholog 2022;80:4-18. https:\/\/doi.org\/10.1111\/his.14443","DOI":"10.1111\/his.14443"},{"key":"10.32074\/1591-951X-1385_ref8","doi-asserted-by":"crossref","unstructured":"Marchetti A, Ferro B, Pasciuto MP, et al. NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategies. Pathologica 2022;114:199-216. https:\/\/doi.org\/10.32074\/1591-951X-787","DOI":"10.32074\/1591-951X-787"},{"key":"10.32074\/1591-951X-1385_ref9","doi-asserted-by":"crossref","unstructured":"Siozopoulou V, Marcq E, De Winne K, et al. NTRK fusions in a sarcomas series: Pathology, molecular and clinical aspects. Pathol Oncol Res 2022;28:1610423. https:\/\/doi.org\/10.3389\/pore.2022.1610423","DOI":"10.3389\/pore.2022.1610423"},{"key":"10.32074\/1591-951X-1385_ref10","doi-asserted-by":"crossref","unstructured":"Church AJ, Calicchio ML, Nardi V, et al. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy. Mod Pathol 2018;31:463-473. https:\/\/doi.org\/10.1038\/modpathol.2017.127","DOI":"10.1038\/modpathol.2017.127"},{"key":"10.32074\/1591-951X-1385_ref11","doi-asserted-by":"crossref","unstructured":"Amatu A, Sartore-Bianchi A, Siena S. NTRK gene fusions as novel targets of cancer therapy across multiple tumour types. ESMO Open 2016;1:e000023. https:\/\/doi.org\/10.1136\/esmoopen-2015-000023","DOI":"10.1136\/esmoopen-2015-000023"},{"key":"10.32074\/1591-951X-1385_ref12","doi-asserted-by":"crossref","unstructured":"Cocco E, Scaltriti M, Drilon A. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol 2018;15:731-747. https:\/\/doi.org\/ 10.1038\/s41571-018-0113-0","DOI":"10.1038\/s41571-018-0113-0"},{"key":"10.32074\/1591-951X-1385_ref13","doi-asserted-by":"crossref","unstructured":"Drilon A, Siena S, Ou SI, et al. Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1). Cancer Discov 2017;7:400-409. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-1237","DOI":"10.1158\/2159-8290.CD-16-1237"},{"key":"10.32074\/1591-951X-1385_ref14","unstructured":"Drilon A, Laetsch TW, Kummar S, et al. Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. N Engl J Med 2018;378:731-739. https:\/\/doi.org10.1056\/NEJMoa1714448."},{"key":"10.32074\/1591-951X-1385_ref15","doi-asserted-by":"crossref","unstructured":"Marchi\u00f2 C, Scaltriti M, Ladanyi M, et al. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research. Ann Oncol 2019;30:1417-1427. https:\/\/doi.org\/10.1093\/annonc\/mdz204","DOI":"10.1093\/annonc\/mdz204"},{"key":"10.32074\/1591-951X-1385_ref16","doi-asserted-by":"crossref","unstructured":"Solomon JP, Benayed R, Hechtman JF, et al. Identifying patients with NTRK fusion cancer. Ann Oncol 2019;30:viii16-viii22. https:\/\/doi.org\/10.1093\/annonc\/mdz384","DOI":"10.1093\/annonc\/mdz384"},{"key":"10.32074\/1591-951X-1385_ref17","doi-asserted-by":"crossref","unstructured":"Hechtman JF, Benayed R, Hyman DM, et al. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions. Am J Surg Pathol 2017;41:1547-1551. https:\/\/doi.org\/10.1097\/PAS.0000000000000911","DOI":"10.1097\/PAS.0000000000000911"},{"key":"10.32074\/1591-951X-1385_ref18","doi-asserted-by":"crossref","unstructured":"Benini S, Gamberi G, Cocchi S, et al. The Efficacy of Molecular Analysis in the Diagnosis of Bone and Soft Tissue: A 15-Year Mono-Institutional Study. Int J Mol Sci 2022;24:632. https:\/\/doi.org\/10.3390\/ijms24010632","DOI":"10.3390\/ijms24010632"},{"key":"10.32074\/1591-951X-1385_ref19","doi-asserted-by":"crossref","unstructured":"Piazzi M, Bavelloni A, Greco S, et al. Expression of the double-stranded RNA-dependent kinase PKR influences osteosarcoma attachment independent growth, migration, and invasion. J Cell Physiol 2020;235:1103-1119. https:\/\/doi.org\/10.1002\/jcp.29024","DOI":"10.1002\/jcp.29024"},{"key":"10.32074\/1591-951X-1385_ref20","doi-asserted-by":"crossref","unstructured":"Palmerini E, Frega G, Gambarotti M, et al. NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case report. Front Oncol. 2023 Oct 9; 13:1252359. https:\/\/https:\/\/doi.org\/10.3389\/fonc.2023.1252359","DOI":"10.3389\/fonc.2023.1252359"},{"key":"10.32074\/1591-951X-1385_ref21","doi-asserted-by":"crossref","unstructured":"Cocchi S, Gambarotti M, Gamberi G, et al. The utility of FISH analysis in the diagnosis of BCOR-rearranged sarcomas. Pathol Res Pract. 2024 Mar;255:155209. https:\/\/https:\/\/doi.org\/10.1016\/j.prp.2024.155209","DOI":"10.1016\/j.prp.2024.155209"},{"key":"10.32074\/1591-951X-1385_ref22","unstructured":"Suumeijer AJH, Antonescu CR. NTRK-rearranged spindle cell neoplasm. In: WHO Classification of Tumours Editorial Board. WHO Classification of Soft Tissue and Bone Tumours. 5th edition. Lyon: International Agency for Research on Cancer (IARC);2020:287-289."},{"key":"10.32074\/1591-951X-1385_ref23","doi-asserted-by":"crossref","unstructured":"Chiang S, Cotzia P, Hyman DM et al. NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma. Am J Surg Pathol 2018 Jun;42:791-798. https:\/\/https:\/\/doi.org\/10.1097\/PAS.0000000000001055","DOI":"10.1097\/PAS.0000000000001055"},{"key":"10.32074\/1591-951X-1385_ref24","doi-asserted-by":"crossref","unstructured":"Kao YC, Sung YS, Argani P, et al. NTRK3 overexpression in undifferentiated sarcomas with YWHAE and BCOR genetic alterations. Mod Pathol 2020;33:1341-1349. https:\/\/doi.org\/10.1038\/s41379-020-0495-2","DOI":"10.1038\/s41379-020-0495-2"},{"key":"10.32074\/1591-951X-1385_ref25","doi-asserted-by":"crossref","unstructured":"Haberecker M, Kuerten P, Vetter VK, et al. A practical approach to better identify NTRK 1-3 fusion-positive mesenchymal neoplasms by pan-Trk immunohistochemistry. Virchows Arch 2025;487:671-680. https:\/\/doi.org\/10.1007\/s00428-025-04102-9. Epub 2025 Apr 15.","DOI":"10.1007\/s00428-025-04102-9"},{"key":"10.32074\/1591-951X-1385_ref26","doi-asserted-by":"crossref","unstructured":"Dang X, Xiang T, Zhao C, et al. EML4-NTRK3 Fusion Cervical Sarcoma: A Case Report and Literature Review. Front Med (Lausanne) 2022;9:832376. https:\/\/doi.org\/10.3389\/fmed.2022.832376","DOI":"10.3389\/fmed.2022.832376"},{"key":"10.32074\/1591-951X-1385_ref27","doi-asserted-by":"crossref","unstructured":"Tannenbaum-Dvir S, Glade Bender JL, Church AJ, et al. Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma. Cold Spring Harb Mol Case Stud 2015;1:a000471. https:\/\/doi.org\/10.1101\/mcs.a000471","DOI":"10.1101\/mcs.a000471"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/1385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:16:08Z","timestamp":1779264968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pathologica.it\/article\/view\/1385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-1385","relation":{},"ISSN":["1591-951X"],"issn-type":[{"value":"1591-951X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"article-number":"3"}}